Description:

Idiopathic dilated cardiomyopathy is an important cause of heart failure. Chronic viral cardiomyopathy (CVC) represents a subset of these patients, where newer molecular diagnostic techniques have enabled the demonstration of detectable levels of viral genome by polymerase chain reaction in the myocardium. In these patients, virus persistence has been associated with adverse outcomes.

BICC was a phase II clinical trial that sought to evaluate the safety and efficacy of 2 doses of beta-int...

Not a Member?

As a member of the ACC, you'll get full access to all articles, clinical research, and more!